Compare MicroSectors FANG and Innovation 3X Leveraged ETN (FNGU) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MicroSectors FANG and Innovation 3X Leveraged ETN vs Tempus AI — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $36.6 (market cap $2.92B), while Tempus AI trades at $70.04 (market cap $12.77B). The key difference: Tempus AI is far larger — about 4.4× MicroSectors FANG and Innovation 3X Leveraged ETN's market cap, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 19 Days and Tempus AI for 22 Days on average.
| FNGU | TEM | |
|---|---|---|
Market Cap | $2.92B | $12.77B |
Volume | 1,949,737 | 8,980,490 |
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $37.20 | $99.28 |
52-Week Low | $13.73 | $41.55 |
Typical Hold Time | 19 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FNGU, a triple-leveraged ETN tracking major tech stocks, trades at $37.2, up 1.92% today with a bullish technical signal from moving averages. Support and resistance levels are tightly clustered near the current price, while oscillators show neutral to overbought conditions. The ETN provides amplified exposure to tech giants but carries inherent leverage risks.
The outlook hinges on the performance of underlying tech holdings; recent news highlights historical volatility, with an 87% loss during past sector downturns. Investors face significant upside potential from tech growth but must weigh extreme volatility and leverage decay risks inherent in the product structure.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About MicroSectors FANG and Innovation 3X Leveraged ETN
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
